Effect of 18.ALPHA.-Glycyrrhetinic acid on the growth of nifedipine responder cell

概要

論文の詳細を見る
We have previously demonstrated that gingival fibroblast obtained from nifedipine reactive patients (nifedipine responder, NIFr) was found to possess higher proliferative activity than fibroblasts obtained from nifedipine non-reactive patients (nifedipine non-responder, NIFn) or normal gingival fibroblast (nifedipine non-treated gingival fibroblast) . 18α-Glycyrrhetinic acid (18α-GA), a constituent of licorice, is a good anti-proliferative agent especially on those cells whose replication rate is slow, by inhibiting the onset of progression. Thus, we examined the effect of 18α-GA to clarify whether it depresses the growth of NIFr. 18α-GA inhibited cell proliferation and G<SUB>1</SUB>/S transition induced by bFGF in NIFr cells. It was also shown that cell cycle control proteins, such as pRB (ser780), pRB (ser807/811), CDK4, CDK6, CDK2, cyclin D1, and cyclin A, were down-stream targets in the growth-inhibition activity of 18α-GA in NIFr cells. In the development of nifedipine-induced gingival overgrowth, an inflammation and the cell growth of NIFr cells are important factors. Based on these findings, 18α-GA, which has anti-inflammatory effect and inhibits growth of NIFr cells, may have a positive role in nifedipine-induced gingival overgrowth therapy.
日本歯科薬物療法学会の論文